At LIMR we engage in basic, preclinical and clinical cancer research. Today, our main focus of research is on disease modifiers that affect inflammation and immunity. Our researchers are world-renowned experts on tumor microenvironments and immune responses—in fact, we are at the forefront of the immunotherapy revolution.
At LIMR, we engage in basic, preclinical and clinical cardiovascular research, and we work closely with our colleagues at the Lankenau Heart Institute, one of the top-performing cardiovascular medicine and surgery centers in the country.
Research for other diseases or conditions
In conjunction with our core research programs in cancer and cardiovascular disease, LIMR investigators also study arthritis, diabetes, lupus, infectious disease, neurological disorders, gastrointestinal disease, regenerative medicine and population health—all with the goal of improving health and well-being.
Center for Population Health Research
Founded in 2016, the Main Line Health Center for Population Health Research (CPHR) at the Lankenau Institute for Medical Research is a joint collaboration between Main Line Health and Thomas Jefferson University’s College of Population Health.